H. Koller (Wien, Austria), A. Wells (London, United Kingdom)
Management of pneumothorax: 3 years data from a district general hospital S. Chandramouli, N. Ekong, P. Rawat, A. Khokhar, M. Babores (Macclesfield, United Kingdom)
| |
Eosinophilic pleural effusions (EPES) M. Zarrouk, M. Kaabi, N. Chaouech, H. Racil, S. Cheikh Rouhou, K. Marnich, A. Chabbou (Tunisia)
| |
Pleural effusions in medical ICU –prevalence, causes and clinical significance G. Gaude (Belgaum, India)
| |
Spontaneous pneumothorax – when, why, how? T. Laisaar, T. Vooder, V. Palmiste-Kallion (Tartu, Estonia)
| |
Evaluation of 276 patients with exudative pleural effusion G. Ortakoylu, A. Bahadir, D. Kanmaz, F. Alkan, G. Ozgul, S. Birer, E. Tuncay, E. Caglar (istanbul, Turkey)
| |
Endoscopic features at patients with thermoinhalation trauma in pulmonology department S. Degtjareva, E. Shmelev, S. Smirnov, O. Lovacheva (Moscow, Russian Federation)
| |
Peculiarities of the articular syndrome in sarcoidosis patients with hystologically verified intrathoracic sarcoidosis I. Vizel, E. Vizel, A. Vizel (Kazan, Russian Federation)
| |
Treatment of sarcoidosis – pentoxifylline O. Tolokh, U. Chulovska, N. Rudnicka (Lviv, Ukraine)
| |
Sarcoidosis onset and clinical data in a large patient series D. Ionita, C. Cilt, C. Tudose, D. Marta, D. Bumbacea, I. Strambu, A. Macri, C. Toma, I. Balcu, I. P. Stoicescu (Bucharest, Romania)
| |
Differences between health status and quality of life in sarcoidosis B. Gvozdenovic, V. Mihailovic Vucinic, V. Zugic, A. Ilic Dudvarski (Belgrade, Republic Of Serbia)
| |
Sarcoidosis and airway obstruction V. Cukic, A. Ustamujic, H. Zutic, I. Sladic, S. Krekic (Sarajevo, Bosnia And Herzegovina)
| |
Endobronchial findings in pulmonary sarcoidosis and their association with clinical and functional parameters D. Ionita, R. Ulmeanu, E. Crisan, M. Alexe, P. Grigore, N. Bisca, R. Nemes, C. Cilt, C. Tudose, D. Bumbacea, D. Marta, I. Strambu, I. P. Stoicescu (Bucharest, Romania)
| |
Evaluation of serum concentration of soluble interleukin-2 receptors (sIL-2R) in different respiratory tract diseases A. Sieminska, E. Jassem, J. M. Slominski (Gdansk, Poland)
| |
Anaemia in a cohort of patients with bronchiectasis A. Dushianthan, S. A. Abbas, Y. Ubidi, M. Jones (Swansea, Kettering, United Kingdom)
| |
Parental expectations and satisfaction concerning antibiotic treatment in children with acute respiratory tract symptoms S. C. Man, C. Tiboc, C. Sabau, M. Jebril, S. A. Tatar (Cluj-Napoca, Romania)
| |
Causes of chronic cough in non smoking patients M. Dabrowska, E. M. Grabczak, J. Domagala-Kulawik, M. Arcimowicz, A. Domeracka-Kolodziej, R. Chazan (Warsaw, Poland)
| |
Causes of chronic cough – comparison between the ACCP guidelines and the JRS guidelines M. Abo, M. Fujimura, K. Nishi, H. Ogawa, Y. Ishiura, N. Ookura, A. Tokuda (Kanazawa, Toyama, Japan)
| |
Prognosis in chronic cough at 3 and 6 monts of follow-up according the presence of aggravating factors A. Pacheco, J. Garcia, V. Faro, J. L. Vallejo, I. Cobeta, A. Royuela (Madrid, Spain)
| |
Soluble forms of CD95 (fas/apo-1), cd38 and CD25 antigens in patients with chronic obstructive pulmonary disease E. Makarowa, N. Menkow, N. Lubavina, V. Novikov (Nizhny Novgorod, Nizhniy Novgorod, Russian Federation)
| |
The assessment of cough severity with the Leicester cough monitor K. K. Y. Chan, G. Cossa, I. Pavord, A. Ing, S. Birring (Campbelltown, Sydney, Australia; Leicester, London, United Kingdom)
| |